Note: The 2012, 2013 publications have not been audited.
Jump to: Publications | Grants and Consultancies | HDR completions
Michael A. Quinn may be from another institution or only recently joined Deakin University.
2011 External
Latifi, Ardian*, Abubaker, Khalid*, Castrechini, Natalie*, Ward, Alister C., Liongue, Clifford, Dobill, Francoise*, Kumar, Janani, Thompson, Erik W.*, Quinn, Michael A.*, Findlay, Jock K.* and Ahmed, Nuzhat* (2011) Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile, Journal of cellular biochemistry, vol. 112, no. 10, pp. 2850-2864, John Wiley & Sons, Inc., Hoboken N.J. [C1]
ERA journal ID: 2235 – Scopus EID: 2-s2.0-80053211466
Citation counts:Scopus - 22,
Thomson - 22
DRO entry for this publication
2007 External
Shield, Kristy, Riley, Clyde*, Quinn, Michael*, Rice, Gregory*, Ackland, Leigh and Ahmed, Nuzhat* (2007) α2β1 integrin affects metastatic potential of ovarian carcinoma spheroids by supporting disaggregation and proteolysis, Journal of carcinogenesis, vol. 6, no. 11, pp. 1-15, BioMed Central, London, England [C1]
ERA journal ID: 16317 – Scopus EID: 2-s2.0-34547141141
Citation counts:Scopus - 32
DRO entry for this publication
No grants and/or consultancies found or audited – the 2012 HERDC financial return has not been completed or loaded as yet.
No completions found or audited.
DRO to publications collection last synchronised: Friday 24th May 2013 10:04pm